Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression
NCT: NCT03653858 · COMPLETED
Реклама
NCT IDNCT03653858
СтатусCOMPLETED
Дата начала2018-09-03
Завершение2026-01-07
Краткое описание
The primary objective of this multicenter, randomized, sham-controlled, double blind (patient and observer blinded) clinical trial is to assess the antidepressant effect of Deep Brain Stimulation (DBS) in patients with treatment resistant major depression using the Boston Scientific implantable Vercise™ GEVIA™ DBS system compared to sham.
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.